Intravesical injection of Botulinum A toxin ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
17	Multiple system atrophy	1

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00822913 (ClinicalTrials.gov)	June 2008	14/1/2009	Botulinum A Toxin in Patients With Parkinson's Disease	The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity.	Parkinson's Disease;Multiple System Atrophy;Detrusor Overactivity	Drug: Intravesical injection of Botulinum A toxin	University Of Perugia	University of Roma La Sapienza	Enrolling by invitation	18 Years	80 Years	Both	20	Phase 4	NULL

17. Multiple system atrophy

---

Clinical trials : 119 /  Drugs : 138 - (DrugBank : 44) / Drug target genes : 59 - Drug target pathways : 111

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00822913 (ClinicalTrials.gov)	June 2008	14/1/2009	Botulinum A Toxin in Patients With Parkinson's Disease	The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity.	Parkinson's Disease;Multiple System Atrophy;Detrusor Overactivity	Drug: Intravesical injection of Botulinum A toxin	University Of Perugia	University of Roma La Sapienza	Enrolling by invitation	18 Years	80 Years	Both	20	Phase 4	NULL